Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-28 5:40 pm Sale | 2025-01-27 | 13D | Acutus Medical, Inc. AFIB | James E. Flynn | 5,492,725 9.100% | -4,213,132 (-43.41%) | Filing History |
| 2025-01-23 9:16 pm Unchanged | 2025-01-21 | 13D | Acutus Medical, Inc. AFIB | James E. Flynn | 9,705,857 9.100% | 0 (Unchanged) | Filing History |
| 2024-12-16 9:52 pm Purchase | 2024-12-12 | 13D | Acutus Medical, Inc. AFIB | James E. Flynn | 9,705,857 9.100% | 28,000 (+0.29%) | Filing History |
| 2024-11-14 1:03 pm Purchase | 2024-09-30 | 13G | Acutus Medical, Inc. AFIB | Lytton, Laurence W. | 2,078,030 7.000% | 331,207 (+18.96%) | Filing History |
| 2024-05-17 5:20 pm Purchase | 2024-05-09 | 13G | Acutus Medical, Inc. AFIB | Lytton, Laurence W. | 1,746,823 5.900% | 1,746,823 (New Position) | Filing History |
| 2023-11-13 4:46 pm Purchase | 2023-11-08 | 13D | Acutus Medical, Inc. AFIB | James E. Flynn | 9,677,857 9.220% | 32,892 (+0.34%) | Filing History |
| 2023-02-13 2:49 pm Sale | 2023-02-14 | 13G | Acutus Medical, Inc. AFIB | Capital World Investors | 797,523 2.800% | -802,477 (-50.15%) | Filing History |
| 2022-07-05 5:15 pm Purchase | 2022-06-30 | 13D | Acutus Medical, Inc. AFIB | James E. Flynn | 9,644,965 9.400% | 3,780,451 (+64.46%) | Filing History |
| 2022-04-27 3:49 pm Purchase | 2022-04-24 | 13D | Acutus Medical, Inc. AFIB | James E. Flynn | 5,864,514 9.400% | 11,590 (+0.20%) | Filing History |
| 2022-02-11 6:04 pm Unchanged | 2021-12-31 | 13G | Acutus Medical, Inc. AFIB | Advent Life Sciences LLP | 1,619,371 5.800% | 0 (Unchanged) | Filing History |
| 2022-02-11 4:04 pm Sale | 2021-12-31 | 13G | Acutus Medical, Inc. AFIB | Kerrisdale Advisers LLC | 0 0.000% | -1,750,920 (Position Closed) | Filing History |
| 2022-02-11 2:48 pm Purchase | 2022-02-14 | 13G | Acutus Medical, Inc. AFIB | Capital World Investors | 1,600,000 5.700% | 1,600,000 (New Position) | Filing History |
| 2021-11-18 4:56 pm Sale | 2021-11-12 | 13D | Acutus Medical, Inc. AFIB | ORBIMED ADVISORS LLC | 2,648,386 9.500% | -4,233,567 (-61.52%) | Filing History |
| 2021-08-31 4:52 pm Purchase | 2021-08-23 | 13D | Acutus Medical, Inc. AFIB | ORBIMED ADVISORS LLC | 6,881,953 7.700% | 1,071,428 (+18.44%) | Filing History |
| 2021-08-26 4:20 pm Purchase | 2021-08-23 | 13D | Acutus Medical, Inc. AFIB | James E. Flynn | 5,852,924 9.500% | 345 (+0.01%) | Filing History |
| 2021-07-21 5:13 pm Purchase | 2021-07-19 | 13D | Acutus Medical, Inc. AFIB | James E. Flynn | 5,852,579 17.190% | 1,071,428 (+22.41%) | Filing History |
| 2021-07-21 09:05 am Purchase | 2021-07-19 | 13G | Acutus Medical, Inc. AFIB | Kerrisdale Advisers LLC | 1,750,920 5.200% | 1,750,920 (New Position) | Filing History |
| 2021-07-13 9:24 pm Unchanged | 2021-07-11 | 13D | Acutus Medical, Inc. AFIB | ORBIMED ADVISORS LLC | 5,810,525 20.400% | 0 (Unchanged) | Filing History |
| 2021-07-13 4:52 pm Purchase | 2021-07-11 | 13D | Acutus Medical, Inc. AFIB | James E. Flynn | 4,781,151 16.750% | 5,235 (+0.11%) | Filing History |
| 2021-02-11 4:15 pm Purchase | 2020-12-31 | 13G | Acutus Medical, Inc. AFIB | Zahir Fares | 1,166,690 4.200% | 1,166,690 (New Position) | Filing History |